262 related articles for article (PubMed ID: 18728403)
1. PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.
Reddy PS; Umesh S; Thota B; Tandon A; Pandey P; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Biol Ther; 2008 May; 7(5):663-8. PubMed ID: 18728403
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
3. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
4. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A1 is upregulated in human glioblastoma.
Knebel FH; Uno M; Galatro TF; Bellé LP; Oba-Shinjo SM; Marie SKN; Campa A
J Neurooncol; 2017 May; 132(3):383-391. PubMed ID: 28283801
[TBL] [Abstract][Full Text] [Related]
7. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
8. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
9. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.
Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM
J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma.
Arvind S; Arivazhagan A; Santosh V; Chandramouli BA
Br J Neurosurg; 2012 Feb; 26(1):16-20. PubMed ID: 21707241
[TBL] [Abstract][Full Text] [Related]
12. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
Vachher M; Arora K; Burman A; Kumar B
J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
[TBL] [Abstract][Full Text] [Related]
13. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.
Rickman DS; Bobek MP; Misek DE; Kuick R; Blaivas M; Kurnit DM; Taylor J; Hanash SM
Cancer Res; 2001 Sep; 61(18):6885-91. PubMed ID: 11559565
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide oligonucleotide microarray analysis of gene-expression profiles of Taiwanese patients with anaplastic astrocytoma and glioblastoma multiforme.
Chang CL
J Biomol Screen; 2008 Oct; 13(9):912-21. PubMed ID: 18812569
[TBL] [Abstract][Full Text] [Related]
16. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
Tanwar MK; Gilbert MR; Holland EC
Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
Patil V; Mahalingam K
Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of sst1, sst2A, and sst3 somatostatin receptor proteins in low-grade and high-grade astrocytomas.
Mawrin C; Schulz S; Pauli SU; Treuheit T; Diete S; Dietzmann K; Firsching R; Schulz S; Höllt V
J Neuropathol Exp Neurol; 2004 Jan; 63(1):13-9. PubMed ID: 14748557
[TBL] [Abstract][Full Text] [Related]
20. NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity.
Venkateshaiah SU; Khan S; Ling W; Bam R; Li X; van Rhee F; Usmani S; Barlogie B; Epstein J; Yaccoby S
Exp Hematol; 2013 Jun; 41(6):547-557.e2. PubMed ID: 23435312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
